ÂÜÀòÂÒÂ×

Tom Borger is an experienced executive with a diverse background in healthcare, technology, and education. Currently serving as an Executive Advisor at both Sidero Bioscience and Tag.bio, Tom Borger focuses on innovative solutions for iron deficiency conditions and data harmonization in drug discovery. As CEO of TB Innovative, Tom Borger leads a consulting firm that emphasizes innovation and strategic marketing. Previous roles include Chief Commercial Officer at Healthe by Lighting Science, Chief Business Officer at Zelira Therapeutics, and Chief Operating Officer at Ilera Healthcare, where Tom Borger advanced medical cannabis developments. Academic contributions include teaching Entrepreneurial Marketing at Villanova University and Small Business Development at Wharton Business School. Tom Borger holds an MBA in Entrepreneurial Management and Marketing from The Wharton School and a BA in Economics from Duke University.